• Issue
    2006
    49-100
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)
Conference Program
Free to Read

International Contrast Media Research Symposium—Program

  • Pages: 49-51
  • First Published: 19 April 2006

WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.01: The hepatobiliary excretion of Gd-BOPTA does not interfere with the clearance of other drugs

V. Lorusso,  G. Pirovano,  A. Spinazzi, 
  • Page: 52
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.02: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver

S. Hirohashi,  N. Tsuda,  T. Tsuji,  N. Katoh, 
  • Page: 52
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.03: Analysis of hepatic uptake of anionic magnetic nanoparticles

E. Lee,  F. Gazeau,  O. Beuf,  J-C. Bacri,  A. Briguet,  M. Janier,  C. Billotey, 
  • Pages: 52-53
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.04: Comparison of VSOP-C184, gadopentetate dimeglumine and ferucarbotran in T1-weighted dynamic and T2-weighted late MRI of focal liver lesions in rabbits

J. Schnorr,  S. Wagner,  C. Abramjuk,  T. Schink,  E. Schellenberger,  H. Pilgrimm,  B. Hamm,  M. Taupitz, 
  • Page: 53
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.05: Does dual-contrast MRI of the liver improve the detection of focal liver lesions? On-site results of a prospective multicenter study

P. Reimer,  C. Wirth,  W. Schima,  T. Vestring,  S. Schönberg,  P. Robinson, 
  • Pages: 53-54
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 1.06: Comparison of liver metastasis detectability from colorectal cancer between SPIO-MRI and diffusion-weighted imaging: how and when should SPIO-MRI be applied?

R. Kuwatsuru,  A. Iwamura,  K. Suzuki,  M. Kono,  K. Machida,  N. Nishii,  T. Hayano,  N. Mitsuhashi, 
  • Page: 54
  • First Published: 19 April 2006

WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.01: High-field MRA with iron oxide blood-pool contrast agents: field strength effects on vascular contrast enhancement in rabbits at 1.5 and 3.0 T

T. Allkemper,  W. Heindel,  H. Kooijman,  W. Ebert,  B. Tombach, 
  • Page: 54
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.02: Interventional double-contrast MR angiography: intra-arterial injections of SPIO particles SHU 555 C (Resovist®) in combination with trueFISP imaging

F.K. Wacker,  R.M. Maes,  J.L. Duerk,  B. Misselwitz,  C.J.M. Kiewiet,  J.S. Lewin, 
  • Pages: 54-55
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.03: VSOP-C184 as contrast agent for MRI of atherosclerotic plaques: experimental results in rabbits

M. Taupitz,  J. Schnorr,  H. Pilgrimm,  B. Hamm,  S. Wagner, 
  • Page: 55
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.04: MRI of cerebral ischemia with ultra-small superparamagnetic particles of iron oxide in mice

M. Wiart,  T.H. Cho,  J.B. Pialat,  O. Beuf,  J.B. Langlois,  N. Nighoghossian,  Y. Berthezene, 
  • Pages: 55-56
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.05: Use of magnetic nanoparticles as intracellular agents for hyperthermia

J.P. Fortin,  C. Wilhelm,  F. Gazeau,  J. Servais,  D. Talbot,  C. Ménager,  J.C. Bacri, 
  • Pages: 56-57
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 2.06: Ferumoxtran-10 enhanced MR imaging in detection of metastases outside the normal surgical area in prostate cancer

J.O. Barentsz,  R. Heesakkers,  A. Hovels,  F. Witjes,  B. Knipscheer,  P. Mulders,  C. Hulsbergen, 
  • Page: 57
  • First Published: 19 April 2006

WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.01: MRI tumor characterization using Gd–GlyMe–DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent

R. Brasch,  H.-J. Raatschen,  Z. Boyd,  D. Shames,  M. Zierhut,  R. Swain,  B. Misselwitz,  H. Weinmann,  M. Wendland, 
  • Page: 57
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.02: The stromal mechanism: an inherent link between necrosis-avid contrast agents and photodynamic therapy

Y. Ni.,  F. Chen,  G. Bormans,  A. Verbruggen,  G. Marchal, 
  • Pages: 57-58
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.03: New RGD peptide-based molecular imaging agents for detection of angiogenesis

B. Indrevoll,  G.M. Kindberg,  H. Karlsen,  M. Mendizabal,  M. Morrison,  A. Healey,  A. Cuthbertson, 
  • Page: 58
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.04: Sentinel node imaging of breast cancer in mice using a dual-labeled nano-sized MRI–near-infrared optical hybrid contrast agent

H. Kobayashi,  V.S. Talanov,  M. Bernardo,  M.W. Brechbiel,  P.L. Choyke, 
  • Pages: 58-59
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.05: In vivo follow-up of Gd-labeled liposome concentrations in rats bearing a glioma: a comparative study

G. Le Duc,  S. Corde,  P. Régnard,  T. Brochard,  C. Nemoz,  A. Werner,  J. Nieland,  H. Haas, 
  • Page: 59
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.06: PEGylated and fluorescent superparamagnetic liposomes provide a promising tool for combining in vivo imaging and therapy

S. Lesieur,  M.S. Martina,  V. Plassat,  J.P. Fortin,  C. Rivière,  G. Barratt,  C. Ménager,  O. Clément,  C. Wilhelm,  F. Gazeau,  Y. Tomita,  J. Seylaz, 
  • Pages: 59-60
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.07: High-Z compounds for synchrotron stereotactic radiotherapy: developments and perspectives

F. Estève,  J.F. Adam,  M.C. Biston,  A. Joubert,  S. Corde,  C. Boudou,  J. Rousseau,  J. Gastaldo,  Z. Bencokova,  J. Rousseau,  A.M. Charvet,  N. Foray,  J.F. Le Bas,  J. Balosso,  H. Elleaume, 
  • Page: 60
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.08: Preliminary imaging results with NM404 in lung cancer patients

J. P. Weichert,  M. A. Longino,  S. Perlman,  A. Pinchuk,  J.H. Schiller, 
  • Pages: 60-61
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 3.09: Preclinical efficacy of 177Lu-AMBA, a radiotherapeutic targeting the GRP receptor

L.E. Lantry,  M.E. Maddalena,  J.S. Fox,  J. Chen,  S.M. Eaton,  N.J. Bogdan,  R. Thomas,  E. Cappelletti,  L. Lattuada,  H. Nguyen,  K.E. Linder,  R.E. Swenson,  M.F. Tweedle,  A.D. Nunn, 
  • Page: 61
  • First Published: 19 April 2006

WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.01.: The mechanism of gadofluorine accumulation in atherosclerotic lesions

J. Meding,  B. Misselwitz,  H.J. Weinmann, 
  • Pages: 61-62
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.02: Targeted MR nanoparticles for local anti-restenotic therapy following angioplasty

T. Cyrus,  S.D. Caruthers,  T.D. Harris,  V. Glattauer,  J. Werkmeister,  J. Ramshaw,  S.A. Wickline,  G.M. Lanza, 
  • Page: 62
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.03: A new contrast agent for magnetic resonance imaging of the vascular walls

F. Chaubet,  E. Canet-Soulas,  Linda Chaabane,  C. Zahir,  I. Brigger,  C. Corot,  D. Letourneur, 
  • Page: 62
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.04: Folate-targeted high-relaxivity gadolinium chelate: in vitro binding affinity evaluation on purified folate-binding protein and on KB tumor cells overexpressing folate receptors

C. Corot,  P. Prigent,  I. Brigger,  S. Ballet,  E. Lancelot,  M. Port, 
  • Pages: 62-63
  • First Published: 19 April 2006
WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.05: Ultra-small supraparamagnetic iron oxide-enhanced MR imaging of antigen-induced arthritis: a comparative study between SH U 555 C, ferumoxtran-10 and ferumoxytol

G.H. Simon,  J. von Vopelius-Feldt,  J. Schlegel,  Y. Fu,  M.F. Wendland,  H.E. Daldrup-Link, 
  • Page: 63
  • First Published: 19 April 2006

WEDNESDAY, 12 OCTOBER 2005
Free to Read

CMR 2005: 4.06: Proof-of-concept of folate receptor-targeted MRI of antigen-induced arthritis

H.E. Daldrup-Link,  O. Saborowski,  G.H. Simon,  M. Wendland,  C. Corot, 
  • Page: 63
  • First Published: 19 April 2006

THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 5.01: Diagnostic imaging with iobitridol: safety in a general population and tolerance in patients with rare risk factors. results in 52 057 patients

R.M. Hammerstingl,  E. Honold,  H. Mohajeri,  T.J. Vogl, 
  • Pages: 63-64
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 5.02: Nephrotoxicity of iodine contrast media, iso-osmolar to plasma, in comparison with gadolinium contrast media after renal arteriography in an experimental porcine model

B. Elmståhl,  P. Leander, 
  • Page: 64
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 5.03: Effect of bicarbonate infusion on contrast-induced nephropathy

R. Towart,  K. Golman, 
  • Pages: 64-66
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 5.04: Dendrimer-based nano-sized contrast agents for functional renal MRI: new insights into pathogenesis of acute renal diseases

H. Kobayashi,  D. James,  S. Kawamoto,  M.W. Brechbiel,  R.A. Star,  P.L. Choyke, 
  • Pages: 66-67
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 5.05: The risk of contrast medium-induced nephropathy should be correlated with the ratio between dose in grams of iodine and estimated glomerular filtration rate

U. Nyman,  P. Aspelin,  G. Sterner,  M. Hellström, 
  • Page: 67
  • First Published: 19 April 2006

THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 6.01: Gadobutrol (1 m) as a contrast agent for CT angiography of the aorta and pulmonary arteries: results with a 16-detector row scanner

J.M. Esteban,  V. Cervera,  A. Batista, 
  • Pages: 67-68
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 6.02: CT urography: utility of 0.5 and 1 m gadolinium chelates compared with an iodinated contrast medium

J.M. Esteban,  F. Sanchez,  F. Ordoño,  J.U. Juan,  V. Cervera, 
  • Page: 68
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 6.03: The efficacy of MultiHance (gadobenate dimeglumine or Gd–BOPTA) at 1.5 and 3 T in a rat brain glioma model

V.M. Runge,  J. Biswas,  B.J. Wintersperger,  S.S. Baumannn,  C.B. Jackson,  C.U. Herborn,  T. Patel, 
  • Pages: 68-69
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 6.04: Blood-pool contrast medium (Vistarem) discriminates acutely infarcted from scarred myocardium on late enhancement

M. Saeed,  O. Weber,  R. Lee,  L. Do,  P. Robert,  C. Corot,  D. Saloner,  C.B. Higgins, 
  • Page: 69
  • First Published: 19 April 2006
THURSDAY, 13 OCTOBER 2005
Free to Read

CMR 2005: 6.05: Phase I clinical trial of gadomer

B. Tombach,  J. Schneider,  P. Reimer,  M. Mahler,  W. Ebert,  K. Shamsi,  W. Heindel, 
  • Page: 69
  • First Published: 19 April 2006

FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.01: Planar and tomographic imaging of expression in human tumor xenografts

A. von Wallbrunn,  C. Höltke,  M. Zühlsdorf,  W. Heindel,  M. Schäfers,  C. Bremer, 
  • Page: 70
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.02: Exploring microvessels using intravital fluorescence microscopy: role of molecular weight of agents

L.S. Fournier,  N. Faye,  O. Clément,  M.S. Martina,  N. Siauve,  C.A. Cuénod, 
  • Page: 70
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.03: Optical imaging of experimental arthritis with DiD-labeled leukocytes before and after cortisone treatment

H.E. Daldrup-Link,  G.H. Simon,  J. Kau,  S. Demos,  B. Pichler, 
  • Pages: 70-71
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.04: Hemoglobin, a physiological contrast medium for optical molecular imaging of the female breast: computed tomography–laser mammography in the differentiation of benign and malignant breast lesions

T.H. Helbich,  C. C. Riedl,  S. Jaromi,  M.H. Fuchsjaeger,  C. Reiner,  D. Floery, 
  • Page: 71
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.05: Contrast-enhanced ultrasound and CT for quantifying response to anti-angiogenic therapy in a rat tumor model

R. Pollard,  A.R. Sadlowski,  E.R. Wisner,  S. Bloch,  S. Griffey,  D. Shalinsky,  K.W. Ferrara, 
  • Pages: 71-72
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.06: Role of perfusion CT in monitoring anti-angiogenic response in patients with advanced hepatocellular carcinoma

D.V. Sahani,  N. Holalkere,  A.X Zhu, 
  • Page: 72
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 7.07: Simultaneous placental perfusion and permeability assessment by dual echo contrast-enhanced MRI in mice

C.A. Cuenod,  F. Taillieu,  L.J. Salomon,  N. Siauve,  O. Clément,  D. Balvay,  C. Vayssettes,  Y. Ville, 
  • Pages: 72-73
  • First Published: 19 April 2006

FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.01: Dextran-coated PFOB emulsion: a potential targeted US contrast agent

Y. Zheng,  D. Vera,  C. Hoh,  R. Mattrey, 
  • Page: 73
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.02: Fibrin-directed nanoparticles for combined imaging and local thrombolytic therapy

J.N. Marsh,  M.S. Hughes,  P.J. Gaffney,  M.J. Scott,  S.A. Wickline,  G.M. Lanza, 
  • Page: 73
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.03: Targeted ultrasound contrast agents for molecular imaging in high-shear flow

A.L. Klibanov,  J.J. Rychak,  W.C. Yang,  B. Li,  S. Acton,  J.R. Lindner,  K.F. Ley,  S. Kaul, 
  • Page: 74
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.04: Shell-rupture detection for single ultrasound contrast microbubbles

A.Y. Ammi,  R.O. Cleveland,  J. Mamou,  G.I. Wang,  O. Lucidarme,  S.L. Bridal,  W.D. O'Brien Jr, 
  • Page: 74
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.05: Effects of high MI exposure during contrast echocardiography with SonoVue™ in the dog

X. Fouillet,  T. Messager,  A. Broillet,  S. Milano,  D. Ravelo,  M. Schneider, 
  • Pages: 74-75
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.06: Contrast-assisted ultrasound for sentinel lymph node detection; the effect of particle characteristics and node status on imaging efficacy

E.R. Wisner,  S.H. Bloch,  P.D. Schneider,  R.E. Short, 
  • Page: 75
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 8.07: Real-time assessment and off-line quantification of flow dynamics in intracranial aneurysms using intra-operative contrast-specified ultrasound

T. Hölscher,  W.G. Wilkening,  S. Singel,  H. Sang U,  S. Hardin,  J. Rodriguez-Rodriguez,  R.F. Mattrey,  J.C. Lasheras, 
  • Pages: 75-76
  • First Published: 19 April 2006

FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.01: Instant magnetic labeling of stem cells using magnetoelectroporation

P. Walczak,  D. Kedziorek,  A.A. Gilad,  S. Lin,  J.W.M. Bulte, 
  • Page: 76
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.02: Detection of single cells by high-field MRI

F. Gazeau,  P. Smirnov,  J.P. Fortin,  C. Wilhelm,  B. Gillet, 
  • Page: 76
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.03: Novel magnetic resonance contrast mechanism for combined tracking of the delivery of mesenchymal stem cells and interventional devices

D.L. Kraitchman,  M. Stuber,  W.D. Gilson,  L.V. Hofmann,  J.W.M. Bulte, 
  • Pages: 76-77
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.04: In vivo single-cell MRI of lymphocytes in tumors at 1.5 T using a superconducting surface coil†

P. Smirnov,  M. Poirier-Quinot,  E. Lavergne,  F. Gazeau,  J.-C. Ginefri,  B. Combadière,  O. Clement,  L. Darrasse, 
  • Pages: 77-78
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.05: Magnetic labeling and in vivo tracking of embryonic stem cells: efficacy, biological effects, high-field detection limits and long-term results

K. Sieland,  A. Stroh,  C. Faber,  T. Neuberger,  K. Weir,  S. Mueller,  P. Lorenz,  T. Grune,  P. Jakob,  M. Taupitz,  H. Pilgrimm,  C. Zimmer, 
  • Page: 78
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.06: Iron oxide nanoparticles as a cell labeling contrast agent for non-invasive long-term cell therapy monitoring by MRI: an abdominal aortic aneurysm model

C. Rivière,  J.F. Deux,  J. Dai,  F. Gazeau,  P. Méric,  J. Roger,  F. Boudghène,  E. Allaire,  D. Letourneur, 
  • Pages: 78-79
  • First Published: 19 April 2006
FRIDAY, 14 OCTOBER 2005
Free to Read

CMR 2005: 9.07: In vivo MR tracking of magnetically labeled dendritic cells: first clinical experience

J. Barentsz,  P. Verdijk,  I. de Vries,  W. Lesterhuis,  T. Scheenen,  O. Boerman,  W. Oyen,  G. Adema,  J. van Krieken,  J. Bulte,  C. Punt,  A. Heerschap,  C. Figdor, 
  • Page: 79
  • First Published: 19 April 2006

SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.01: Radiodiagnostic examinations with iodinated contrast media may result in severe DNA damage resulting in cellular radiosensitization

A. Joubert,  J.L. Ravanat,  F. Estève,  J. Balosso,  N. Foray, 
  • Pages: 79-80
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.02: Vector-electrocardiographic changes in pigs indicating risk of ventricular fibrillation after injections into the left coronary artery of mannitol or iodixanol solutions with or without electrolytes

T. Almén,  C.-M. Chai,  L. Bååth,  J. Besjakov, 
  • Page: 80
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.03: Current concepts in the evaluation of immediate allergic reactions to contrast agents

P. Dewachter,  D. Laroche,  C. Mouton-Faivre MD,  O. Clément, 
  • Pages: 80-81
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.04: Immediate reactions following ICM injection: results of a 3-year prospective multicenter survey

D. Laroche,  P. Dewachter,  C. Mouton-Faivre,  O. Clément, 
  • Page: 81
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.05: Immunological mechanisms of delayed-type hypersensitivity reactions to iodinated contrast media

M. Lerch,  M. Keller,  M. Britschgi,  G. Kanny,  V. Tâche,  D. Schmid,  B.O. Gerber,  A.J. Bircher,  C. Christiansen,  W.J. Pichler, 
  • Pages: 81-82
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity

K. Brockow,  C. Christiansen,  W. Aberer,  A. Barbaud,  A. Bircher,  G. Kanny,  W.J. Pichler,  J. Ring,  A. Romano,  I. Szantho von Radnoth, 
  • Page: 82
  • First Published: 19 April 2006

SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.01: High-resolution x-ray microtomography of spleen in living mice

M. Almajdub,  L. Magnier,  E. Chereul,  M. Janier, 
  • Pages: 82-83
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.02: Micro-CT and micro-DSA of small animal models of disease using iodinated conventional and blood pool contrast agents

C. Badea,  L. Hedlund,  M. Lin,  J. Boslego,  G.A. Johnson, 
  • Page: 83
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.03: Phage display screening for peptides targeting the amyloid peptide Aβ1–42 for molecular imaging of the senile plaques in Alzheimer disease

C. Burtea,  L. Larbanoix,  S. Laurent,  G. Toubeau,  L. Vander Elst,  R.N. Muller, 
  • Pages: 83-84
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.04: Stealthy magnetophages, a new tool for molecular imaging

J. Segers,  C. Laumonier,  S. Laurent,  L. Vander Elst,  R. N. Muller, 
  • Page: 84
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.05: Use of in vivo imaging to follow siRNA-mediated reporter gene inhibition in a transgenic mouse skin model

Q. Wang,  C.H. Contag,  H. Ilves,  Y.-A. Cao,  B.H. Johnston,  R.L. Kaspar, 
  • Page: 85
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.06: Ultra-small iron oxide nanoparticle (USPIO)-labeled baculoviruses as novel MRI agents for imaging viral vector biodistribution in vivo

J. Hakumäki,  J. Räty,  T. Wirth,  T. Huhtala,  T. Ihalainen,  M. Vihinen-Ranta,  A. Närvänen,  S. Ylä-Herttuala, 
  • Page: 85
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 12.07: In vivo magnetic resonance imaging: use of extracellular contrast agent to quantify the efficiency and the toxicity of gene electrotransfer in rat muscle

A. Leroy-Willig,  M.F. Bureau, 
  • Pages: 85-86
  • First Published: 19 April 2006

SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.01: Mannosyl-dextran: a potential multi-modality contrast agent targeting at mannose receptor

Y. Zheng,  R. Mattrey,  J. Feramisco,  D. Vera, 
  • Page: 86
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.02: Doubly luminescent gadolinium oxide nanoparticles as contrast agents for MRI

J.-L. Bridot,  C. Louis,  S. Roux,  C. Marquette,  C. Billotey,  O. Beuf,  P. Perriat,  O. Tillement, 
  • Pages: 86-87
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.03: Relaxivity of gadopentetate dimeglumine, gadobutrol and gadobenate dimeglumine in human blood plasma at 0.2, 1.5 and 3 T

F. Schick,  J. Pintaske,  P. Martirosian,  H. Graf,  G. Erb,  K-P. Lodemann,  C.D. Claussen, 
  • Page: 87
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.04: Design and pharmacomodulation of high-relaxivity MR contrast agents

M. Port,  C. Corot,  O. Rousseaux,  I. Raynal,  P. Bourrinet, 
  • Pages: 87-88
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.05: A temperature-sensitive contrast mechanism for MRI: Curie temperature transition-based imaging

T.P.L. Roberts,  F. Settecase,  M.S. Sussman, 
  • Page: 88
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.06: Activatable MRI CEST agents that detect enzyme activities

M.D. Pagel,  B. Yoo,  G. Liu,  R. Rosenblum, 
  • Pages: 88-89
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 13.07: Novel applications in the field of MRI CEST agents

S. Aime,  D. Delli Castelli,  E. Terreno,  F. Uggeri, 
  • Page: 89
  • First Published: 19 April 2006

SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.01: In vivo structural and functional imaging of the mouse spinal cord using manganese-enhanced MRI

B. Stieltjes,  S. Klussmann,  A. Martin-Villalba,  M. Bock,  M. Essig, 
  • Pages: 89-90
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.02: Abdominal MRI made easy with orally administered manganese: a liver-specific contrast agent and a bowel marker

P. Leander,  P. Höglund,  K. Golman,  G. Pettersson,  S. Månsson, 
  • Page: 90
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.03: Preliminary clinical experience with oral manganese (CMC-001) for liver imaging in daily routine

H.S. Thomsen,  E. Chabanova,  J. Moller,  P. Leth,  H. Dekker,  J. Barentsz,  V. Loegager, 
  • Page: 90
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.04: Oral manganese as contrast medium in detecting liver metastases with MR imaging at 1.5 and 3 T

H. Dekker,  C. van Herpen,  Y. Hoogeveen,  H. Thomsen,  T. Ruers,  J. Barentsz, 
  • Pages: 90-91
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.05: First use of intra-articular carbon dioxide for MR arthrography; a feasibility study

R.M. Maes,  J.S. Lewin,  J.L. Duerk,  C.J.M. Kiewiet,  F.K. Wacker, 
  • Page: 91
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.06: Noninvasive hyperpolarized helium-3 imaging studies in rats under spontaneous breathing conditions using a retrospective radial cine imaging technique

V. Stupar,  E. Canet-Soulas,  S. Gaillard,  H. Alsaid,  N. Beckmann,  Y. Crémillieux, 
  • Pages: 91-92
  • First Published: 19 April 2006
SATURDAY, 15 OCTOBER 2005
Free to Read

CMR 2005: 14.07: Investigation of ozone exposure effects on rat pulmonary function using hyperpolarized helium-3

Y. Crémillieux,  Y. Berthezène,  S. Servais,  D. Dupuich,  A. Boussouar,  V. Stupar,  J.-M. Péquignot, 
  • Page: 92
  • First Published: 19 April 2006

Current Awareness
Free to Read

Current Awareness in Contrast Media and Molecular Imaging

  • Pages: 93-100
  • First Published: 19 April 2006